PaxMedica, Inc. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
PaxMedica, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q1 2024.
- PaxMedica, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$3.69M, a 8.58% increase year-over-year.
- PaxMedica, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$15.8M, a 25% decline year-over-year.
- PaxMedica, Inc. annual Operating Income (Loss) for 2023 was -$16.1M, a 52.3% decline from 2022.
- PaxMedica, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 47.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)